Annual Revenue
$683.00 K
+$195.00 K+39.96%
December 31, 2024
Summary
- As of March 6, 2025, CRDF annual revenue is $683.00 thousand, with the most recent change of +$195.00 thousand (+39.96%) on December 31, 2024.
- During the last 3 years, CRDF annual revenue has risen by +$324.00 thousand (+90.25%).
- CRDF annual revenue is now at all-time high.
Performance
CRDF Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$151.00 K
-$14.00 K-8.48%
December 31, 2024
Summary
- As of March 6, 2025, CRDF quarterly revenue is $151.00 thousand, with the most recent change of -$14.00 thousand (-8.48%) on December 31, 2024.
- Over the past year, CRDF quarterly revenue has dropped by -$14.00 thousand (-8.48%).
- CRDF quarterly revenue is now -28.61% below its all-time high of $211.50 thousand, reached on September 30, 2012.
Performance
CRDF Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$684.00 K
-$5000.00-0.73%
December 31, 2024
Summary
- As of March 6, 2025, CRDF TTM revenue is $684.00 thousand, with the most recent change of -$5000.00 (-0.73%) on December 31, 2024.
- Over the past year, CRDF TTM revenue has dropped by -$5000.00 (-0.73%).
- CRDF TTM revenue is now -0.73% below its all-time high of $689.00 thousand, reached on September 30, 2024.
Performance
CRDF TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CRDF Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.0% | -8.5% | -0.7% |
| 3 y3 years | +90.3% | +104.0% | +89.5% |
| 5 y5 years | +179.2% | +104.0% | +89.5% |
CRDF Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.3% | -26.3% | +104.0% | -0.7% | +90.5% |
| 5 y | 5-year | at high | +179.2% | -26.3% | +251.2% | -0.7% | +179.6% |
| alltime | all time | at high | +179.2% | -28.6% | +346.8% | -0.7% | +667.7% |
Cardiff Oncology Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $683.00 K(+40.0%) | $151.00 K(-8.5%) | $684.00 K(-0.7%) |
| Sep 2024 | - | $165.00 K(+1.2%) | $689.00 K(+3.6%) |
| Jun 2024 | - | $163.00 K(-20.5%) | $665.00 K(+9.0%) |
| Mar 2024 | - | $205.00 K(+31.4%) | $610.00 K(+25.0%) |
| Dec 2023 | $488.00 K(+26.4%) | $156.00 K(+10.6%) | $488.00 K(+6.1%) |
| Sep 2023 | - | $141.00 K(+30.6%) | $460.00 K(+11.7%) |
| Jun 2023 | - | $108.00 K(+30.1%) | $412.00 K(+4.3%) |
| Mar 2023 | - | $83.00 K(-35.2%) | $395.00 K(+2.3%) |
| Dec 2022 | $386.00 K(+7.5%) | $128.00 K(+37.6%) | $386.00 K(-1.3%) |
| Sep 2022 | - | $93.00 K(+2.2%) | $391.00 K(+1.8%) |
| Jun 2022 | - | $91.00 K(+23.0%) | $384.00 K(+6.4%) |
| Mar 2022 | - | $74.00 K(-44.4%) | $361.00 K(+0.6%) |
| Dec 2021 | $359.00 K(-1.9%) | $133.00 K(+54.7%) | $359.00 K(+4.1%) |
| Sep 2021 | - | $86.00 K(+26.5%) | $345.00 K(-12.7%) |
| Jun 2021 | - | $68.00 K(-5.6%) | $395.00 K(+6.8%) |
| Mar 2021 | - | $72.00 K(-39.5%) | $370.00 K(+1.1%) |
| Dec 2020 | $366.00 K(+49.6%) | $119.00 K(-12.5%) | $366.00 K(+7.8%) |
| Sep 2020 | - | $136.00 K(+216.3%) | $339.60 K(+33.0%) |
| Jun 2020 | - | $43.00 K(-36.8%) | $255.30 K(+1.9%) |
| Mar 2020 | - | $68.00 K(-26.6%) | $250.60 K(+2.5%) |
| Dec 2019 | $244.60 K(-35.3%) | $92.60 K(+79.1%) | $244.60 K(+6.3%) |
| Sep 2019 | - | $51.70 K(+35.0%) | $230.00 K(-13.8%) |
| Jun 2019 | - | $38.30 K(-38.2%) | $266.70 K(-21.6%) |
| Mar 2019 | - | $62.00 K(-20.5%) | $340.20 K(-10.1%) |
| Dec 2018 | $378.30 K(-25.1%) | $78.00 K(-11.8%) | $378.30 K(-22.0%) |
| Sep 2018 | - | $88.40 K(-20.9%) | $485.30 K(-6.7%) |
| Jun 2018 | - | $111.80 K(+11.7%) | $520.20 K(+1.9%) |
| Mar 2018 | - | $100.10 K(-45.9%) | $510.40 K(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $505.40 K(+32.6%) | $185.00 K(+50.0%) | $505.30 K(+30.1%) |
| Sep 2017 | - | $123.30 K(+20.9%) | $388.40 K(+9.7%) |
| Jun 2017 | - | $102.00 K(+7.4%) | $354.20 K(-0.4%) |
| Mar 2017 | - | $95.00 K(+39.5%) | $355.60 K(-6.7%) |
| Dec 2016 | $381.10 K(+21.8%) | $68.10 K(-23.6%) | $381.10 K(-2.8%) |
| Sep 2016 | - | $89.10 K(-13.8%) | $392.20 K(+8.8%) |
| Jun 2016 | - | $103.40 K(-14.2%) | $360.40 K(+14.2%) |
| Mar 2016 | - | $120.50 K(+52.1%) | $315.50 K(-2.0%) |
| Dec 2015 | $312.80 K(+11.6%) | $79.20 K(+38.2%) | $322.00 K(+7.6%) |
| Sep 2015 | - | $57.30 K(-2.1%) | $299.20 K(+0.0%) |
| Jun 2015 | - | $58.50 K(-53.9%) | $299.10 K(+1.0%) |
| Mar 2015 | - | $127.00 K(+125.2%) | $296.20 K(+5.7%) |
| Dec 2014 | $280.20 K(+8.1%) | $56.40 K(-1.4%) | $280.20 K(+3.3%) |
| Sep 2014 | - | $57.20 K(+2.9%) | $271.20 K(+5.2%) |
| Jun 2014 | - | $55.60 K(-49.9%) | $257.80 K(+2.6%) |
| Mar 2014 | - | $111.00 K(+134.2%) | $251.20 K(-3.1%) |
| Dec 2013 | $259.20 K(-42.5%) | $47.40 K(+8.2%) | $259.30 K(-30.9%) |
| Sep 2013 | - | $43.80 K(-10.6%) | $375.20 K(-30.9%) |
| Jun 2013 | - | $49.00 K(-58.9%) | $542.90 K(+1.4%) |
| Mar 2013 | - | $119.10 K(-27.1%) | $535.40 K(+18.8%) |
| Dec 2012 | $450.40 K(+74.8%) | $163.30 K(-22.8%) | $450.50 K(+40.3%) |
| Sep 2012 | - | $211.50 K(+409.6%) | $321.00 K(+95.1%) |
| Jun 2012 | - | $41.50 K(+21.3%) | $164.50 K(-18.9%) |
| Mar 2012 | - | $34.20 K(+1.2%) | $202.90 K(-21.3%) |
| Dec 2011 | $257.70 K(-3.0%) | $33.80 K(-38.5%) | $257.80 K(+15.1%) |
| Sep 2011 | - | $55.00 K(-31.2%) | $224.00 K(+32.5%) |
| Jun 2011 | - | $79.90 K(-10.3%) | $169.00 K(+89.7%) |
| Mar 2011 | - | $89.10 K | $89.10 K |
| Dec 2010 | $265.70 K | - | - |
FAQ
- What is Cardiff Oncology annual revenue?
- What is the all time high annual revenue for Cardiff Oncology?
- What is Cardiff Oncology annual revenue year-on-year change?
- What is Cardiff Oncology quarterly revenue?
- What is the all time high quarterly revenue for Cardiff Oncology?
- What is Cardiff Oncology quarterly revenue year-on-year change?
- What is Cardiff Oncology TTM revenue?
- What is the all time high TTM revenue for Cardiff Oncology?
- What is Cardiff Oncology TTM revenue year-on-year change?
What is Cardiff Oncology annual revenue?
The current annual revenue of CRDF is $683.00 K
What is the all time high annual revenue for Cardiff Oncology?
Cardiff Oncology all-time high annual revenue is $683.00 K
What is Cardiff Oncology annual revenue year-on-year change?
Over the past year, CRDF annual revenue has changed by +$195.00 K (+39.96%)
What is Cardiff Oncology quarterly revenue?
The current quarterly revenue of CRDF is $151.00 K
What is the all time high quarterly revenue for Cardiff Oncology?
Cardiff Oncology all-time high quarterly revenue is $211.50 K
What is Cardiff Oncology quarterly revenue year-on-year change?
Over the past year, CRDF quarterly revenue has changed by -$14.00 K (-8.48%)
What is Cardiff Oncology TTM revenue?
The current TTM revenue of CRDF is $684.00 K
What is the all time high TTM revenue for Cardiff Oncology?
Cardiff Oncology all-time high TTM revenue is $689.00 K
What is Cardiff Oncology TTM revenue year-on-year change?
Over the past year, CRDF TTM revenue has changed by -$5000.00 (-0.73%)